RHOA and Alzheimer disease: An overexpression of Pyk2 in the hippocampi of AD model mice leads to synapse loss via the inhibitory interaction of Pyk2 with Graf1, which leads to increased RhoA activity and consequent actomyosin contractility and dendritic spine retraction [39].